https://www.clinrol.com/study/562
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With...
Phase 3b study assessing efficacy and safety of remibrutinib vs. continuous ocrelizumab in patients with relapsing multiple sclerosis.
living withefficacysafetyremibrutinibswitching
https://ctv.veeva.com/study/a-study-to-evaluate-efficacy-of-remibrutinib-compared-to-dupilumab-at-early-timepoints-in-adults-wit?comeFrom=%7B%22type%22%3A%22site%22%2C%22slug%22%3A%22research-solutions-of-arizona-litchfield-park-az%22%7D
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults...
This is a US, multi-center, randomized, double-blind, double-dummy, Phase 3b study to evaluate efficacy of remibrutinib (25 mg twice daily \[b.i.d.\] by mouth...
a studyevaluateefficacyremibrutinibcompared